G

Genelux Corp
D

GNLX

2.57000
USD
0.05
(1.98%)
مغلق
حجم التداول
3,982
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
116,280,511
أصول ذات صلة المقالات
المزيد

العنوان: Genelux Corp

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune responseagainst tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.